The DIAN-TU Trial Overview and Next Steps

Description: An overview of recent developments and plans for upcoming and ongoing research through the DIAN Trials Unit, with special focus on tau-targeting potential treatments
Runtime: 00:17:41

Speaker: Randall Bateman, MD
Speaker title: DIAN Trials Unit Director
Speaker organization: Washington University in St. Louis

Event: 2022 DIAD Family Conference: (re)UNITED!
Location: San Diego, California, USA
Year: 2022

Search tags: clinical trials, research participation, secondary prevention, public-private partnership, preclincal Alzheimer’s, lecanemab, E2814, DIAN-TU-001 trial, DIAN history, ganternerumab, DIAN-TU NexGen Trials, anti-tau monoclonal antibodies, genetic treatments, tau ASOs, open-label extension, combination therapy, Cognitive Run-In, biomarkers, study design